|
|
|
|
| LEADER |
00000cam a2200000Ia 4500 |
| 001 |
in00002543305 |
| 005 |
20211202192538.0 |
| 006 |
m d f |
| 007 |
cr an||||||||| |
| 008 |
091130s2009 mdud s f000 0 eng d |
| 035 |
|
|
|a (OCoLC)ocn471496781
|
| 040 |
|
|
|a GPO
|c GPO
|d GPO
|d MvI
|d UtOrBLW
|
| 043 |
|
|
|a n-us---
|
| 049 |
|
|
|a WWW
|
| 074 |
|
|
|a 0499-T (online)
|
| 086 |
0 |
|
|a HE 20.4702:IM 7/5
|
| 245 |
0 |
0 |
|a Guidance for industry :
|b ANDAs, impurities in drug substances.
|
| 246 |
3 |
0 |
|a ANDAs, impurities in drug substances
|
| 264 |
|
1 |
|a Rockville, MD :
|b U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research,
|c [2009]
|
| 300 |
|
|
|a 1 online resource (8 pages) :
|b chart.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a "Office of Generic Drugs."
|
| 500 |
|
|
|a "Revision 1."
|
| 500 |
|
|
|a "June 2009."
|
| 500 |
|
|
|a Electronic resource.
|
| 650 |
|
0 |
|a Drug adulteration
|x Government policy
|z United States.
|
| 650 |
|
0 |
|a Drug approval
|z United States.
|
| 710 |
2 |
|
|a Center for Drug Evaluation and Research (U.S.).
|b Office of Generic Drugs.
|
| 856 |
4 |
0 |
|u https://purl.fdlp.gov/GPO/LPS117047
|t 0
|
| 999 |
|
|
|a MARS
|
| 999 |
f |
f |
|s 0c939ac3-3376-3c24-a802-1ac2ddcd5559
|i 7c0123d4-3c7e-311f-a9aa-5ef6dc550841
|t 0
|
| 952 |
f |
f |
|a Texas A&M University
|b College Station
|c Electronic Resources
|d Available Online
|t 0
|e HE 20.4702:IM 7/5
|h Superintendent of Documents classification
|
| 998 |
f |
f |
|a HE 20.4702:IM 7/5
|t 0
|l Available Online
|